Status:
UNKNOWN
Good Use of Normal Human ImmunoGlobulins (NHIg): Feasibility of Integrating the Criteria of Hierarchy During of NHIg Dispensations
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Immunoglobulins
Eligibility:
All Genders
18-100 years
Brief Summary
Supply of Normal Human Immunoglobulins (NHIg) has been in steady tension for almost 15 years in the world. The scarcity of raw material, manufacturing time by industries, and increase consumptions are...
Eligibility Criteria
Inclusion
- Patients treated with NHIg for one of the following 3 indications between 01/10/2021 and 31/12/2021: TIP, CDIP and SID.
- Patients 18 years of age and older
Exclusion
- Patient Objection
- Patients treated with NHIg- for another indication
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06027450
Start Date
September 1 2023
End Date
December 1 2023
Last Update
September 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.